Jonathan Glass

Jonathan D. Glass is Professor of Neurology and Pathology, and the Director of the Emory ALS Center in the Department of Neurology at Emory University in Atlanta, Georgia. He is widely known for his research on the pathogenesis and prevention of nerve degeneration in neurological diseases, and for his work in human and experimental neuropathology.

The Emory ALS Center has grown to be one of the largest clinical centers in the Southeast. Additionally, he is Co-Chair of the Northeast ALS Consortium (NEALS), an organization dedicated to advancing clinical research for ALS patients and their families.

Dr. Glass’s laboratory currently focuses on the causes of nerve degeneration in animal models of neurological diseases, including the development of novel therapeutic interventions to prevent the death of nerve fibers. Glass is a passionate advocate for bringing science to the clinic, and involving patients in the study of their own disease. Currently, he is exploring the biological markers of disease activity and progression in collaboration with ALS patients.

He is also the principal investigator for the current first-in-human, phase 1 study of spinal cord injection of neural stem cells for patients with ALS (funded by Neuralstem, Inc). Dr. Glass is an active clinician who has been cited each year since 2001 as one of "America's Top Doctors" and since 2005 as one of the very few neurologists in "Atlanta's Top Doctors.”

Glass is also a teacher and mentor to young physicians and served as the director of Emory's Neurology residency program from 2001-2006. He received his undergraduate degree from Middlebury College in Vermont and his MD from the University of Vermont. He trained in Neurology and Neuropathology at Johns Hopkins, where he was a faculty member until moving to Emory in 1996.